Cross-regulation of signaling by ITAM-associated receptors

Nature Immunology

Volumn 10, Issue 4, 2009, Pages 340-347

  Ivashkiv, Lionel B ^a  

^a HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 INTEGRIN; CYTOKINE; CYTOKINE RECEPTOR; FC RECEPTOR; JANUS KINASE; KILLER CELL ACTIVATING RECEPTOR ASSOCIATED PROTEIN; STAT PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ANTIGEN ANTIBODY COMPLEX; BINDING AFFINITY; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; ENDOTOXEMIA; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE ACTIVATION; MOLECULAR BIOLOGY; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; PROTEIN VARIANT; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD18; HUMANS; IMMUNOGLOBULIN VARIABLE REGION; JANUS KINASES; MEMBRANE PROTEINS; RECEPTOR CROSS-TALK; RECEPTORS, CELL SURFACE; RECEPTORS, CYTOKINE; RECEPTORS, IMMUNOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TOLL-LIKE RECEPTORS;

EID: 62849123774     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.1706     Document Type: Review

References (97)

1. Abram, C.L. & Lowell, C.A. The expanding role for ITAM-based signaling pathways in immune cells. Sci. STKE 2007, re2 (2007).
2. + T-cell anergy. Nat. Rev. Immunol. 7, 599-609 (2007).
3. Hamerman, J.A. & Lanier, L.L. Inhibition of immune responses by ITAM-bearing receptors. Sci. STKE 2006, re1 (2006).
4. Zou, W., Reeve, J.L., Liu, Y., Teitelbaum, S.L. & Ross, F.P. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk. Mol. Cell 31, 422-431 (2008).
5. Ivashkiv, L.B. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat. Rev. Immunol. 8, 816-822 (2008).
6. Abtahian, F. et al. Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells. Mol. Cell. Biol. 26, 6936-6949 (2006).
7. Mocsai, A. et al. Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat. Immunol. 7, 1326-1333 (2006).
8. 3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption. J. Cell Biol. 176, 877-888 (2007).
9. Ravetch, J.V. & Lanier, L.L. Immune inhibitory receptors. Science 290, 84-89 (2000).
10. Turnbull, I.R. & Colonna, M. Activating and inhibitory functions of DAP12. Nat. Rev. Immunol. 7, 155-161 (2007).
11. Underhill, D.M. & Goodridge, H.S. The many faces of ITAMs. Trends Immunol. 28, 66-73 (2007).
12. Hamerman, J.A. et al. Cutting edge: Inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J. Immunol. 177, 2051-2055 (2006).
13. Hamerman, J.A., Tchao, N.K., Lowell, C.A. & Lanier, L.L. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat. Immunol. 6, 579-586 (2005).
14. Turnbull, I.R. et al. Cutting edge: TREM-2 attenuates macrophage activation. J. Immunol., 177, 3520-3524 (2006).
15. Turnbull, I.R. et al. DAP12 (KARAP) amplifies inflammation and increases mortality from endotoxemia and septic peritonitis. J. Exp. Med. 202, 363-369 (2005).
16. Kanamaru, Y. et al. Inhibitory ITAM signaling by FcαRI-FcRγ chain controls multiple activating responses and prevents renal inflammation. J. Immunol. 180, 2669-2678 (2008).
17. Pasquier. B. et al. Identification of FcαRI as an inhibitory receptor that controls inflammation: Dual role of FcRγ ITAM; Immunity 22, 31-42 (2005).
18. Pinheiro da Silva, F. et al. CD16 promotes Escherichia coli sepsis through an FcRγ inhibitory pathway that prevents phagocytosis and facilitates inflammation. Nat. Med. 13, 1368-1374 (2007).
19. Klesney-Tait, J., Tumbull, I.R. & Colonna, M. The TREM receptor family and signal integration. Nat. Immunol. 7, 1266-1273 (2006).
20. Lorenzo, J., Horowitz, M. & Choi, Y. Osteoimmunology: Interactions of the bone and immune system. Endocr. Rev. 29, 403-440 (2008).
21. Takayanagi, H. Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7, 292-304 (2007).
22. Teitelbaum, S.L. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res. Ther. 8, 201 (2006).
23. Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901 (2002).
24. Aliprantis, A.O. et al. NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism. J. Clin. Invest. 118, 3775-3789 (2008).
25. Humphrey, M.B. et al. TREM2, a DAP12-associated receptor, regulates osteoclast differentiation and function. J. Bone Miner. Res. 21, 237-245 (2006).
26. Kega, T. et al. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428, 758-763 (2004).
27. Mao, D., Epple, H., Uthgenannt, B., Novack, D.V. & Faccio, R. PLCγ2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2. J. Clin. Invest. 116, 2869-2879 (2006).
28. Mocsai, A. et al. The immunomodulatory adapter proteins DAP12 and Fc receptor gamma-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase. Proc. Natl. Acad. Sci. USA 101, 6158-6163 (2004).
29. Kaifu, T. et al. Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice. J. Clin. Invest. 111, 323-332 (2003).
30. Nataf, S. et al. Brain and bone damage in KARAP/DAP12 loss-of-function mice correlate with alterations in microglia and osteoclast lineages. Am. J. Pathol. 166, 275-286 (2005).
31. Cella, M. et al. Impaired differentiation of osteoclasts in TREM-2-deficient individuals. J. Exp. Med. 198, 645-651 (2003).
32. Paloneva, J. et al. Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts. Nat. Genet. 25, 357-361 (2000).
33. Paloneva, J. et al. Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. Am. J. Hum. Genet. 71, 656-662 (2002).
34. Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261-1269 (2005).
35. Lee, S.H., Kim, T., Jeong, D., Kim, N. & Choi, Y. The tec family tyrosine kinase Btk regulates RANKL-induced osteoclast maturation. J. Biol. Chem. 283, 11526-11534 (2008).
36. Shinohara, M. et al. Tyrosine kinases Btk and Tec regulate osteoclast differentiation by linking RANK and ITAM signals. Cell 132, 794-806 (2008).
37. Bezman, N. & Koretzky, G.A. Compartmentalization of ITAM and integrin signaling by adapter molecules. Immunol. Rev. 218, 9-28 (2007).
38. Epple, H. et al. Phospholipase Cγ2 modulates integrin signaling in the osteoclast by affecting the localization and activation of Src kinase. Mol. Cell. Biol. 28, 3610-3622 (2008).
39. Kang, Y.J. et al. Calcineurin negatively regulates TLR-mediated activation pathways. J. Immunol. 179, 4598-4607 (2007).
40. Tassiulas, I. et al. Amplification of IFN-α-induced STAT1 activation and inflammatory function by Syk and ITAM-containing adaptors. Nat. Immunol. 5, 1181-1189 (2004).
41. Wang, L. et al. 'Tuning' of type I interferon-induced Jak-STAT1 signaling by calcium-dependent kinases in macrophages. Nat. Immunol. 9, 186-193 (2008).
42. Takegahara, N. et al. Plexin-A1 and its interaction with DAP12 in immune responses and bone homeostasis. Nat. Cell Biol. 8, 615-622 (2006).
43. Radhakrishnan, S. et al. TREM-2 mediated signaling induces antigen uptake and retention in mature myeloid dendritic cells. J. Immunol. 181, 7863-7872 (2008).
44. Stadanlick, J.E. et al. Tonic B cell antigen receptor signals supply an NF-κB substrate for prosurvival BLyS signaling. Nat. Immunol. 9, 1379-1387 (2008).
45. Yamashita, T. et al. NF-κB p5O and p52 regulate receptor activator of NF-κB ligand (RANKL) and tumor necrosis factor-induced osteoclast precursor differentiation by activating c-Fos and NFATc1. J. Biol. Chem. 282, 18245-18253 (2007).
46. Vaira, S. et al. ReIB is the NF-κB subunit downstream of NIK responsible for osteoclast differentiation. Proc. Natl. Acad. Sci. USA 105, 389-3902 (2008).
47. Brown, G.D. et al. Dectin-1 mediates the biological effects of β-glucans. J. Exp. Med. 197, 1119-1124 (2003).
48. Gantner, B.N., Simmons, R.M., Canavera, S.J., Akira, S. & Underhill, D.M. Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J. Exp. Med. 197, 1107-1117 (2003).
49. Rogers, N.C. et al. Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507-517 (2005).
50. Boule, M.W. et al. Toll-like receptor 9-dependent and independent dendritic cell activation by chromatin-immunoglobulin G complexes. J. Exp. Med. 199, 1631-1640 (2004).
51. LeibundGut-Landmann, S. et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007).
52. 2 integrins are involved in cytokine responses to whole Gram-positive bacteria. J. Immunol. 164, 5871-5876 (2000).
53. 3 complex senses bacterial lipopeptides via vitronectin. Nat. Immunol. 9 761-768 (2008).
54. Kagan, J.C. & Medzhitov, R. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955 (2006).
55. Akira, S. & Takeda, K. Toll-like receptor signalling. Nat. Rev. Immunol. 4, 499-511 (2004).
56. Gross, O. et al. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442, 651-656 (2006).
57. Gross, O. et al. Multiple ITAM-coupled NK-cell receptors engage the Bcl 10/Malt1 complex via Carmal for NF-κB and MAPK activation to selectively control cytokine production. Blood 112, 2421-2428 (2008).
58. Hira, H. et al. The adaptor protein CARD9 is essential for the activation of myeloid cells through ITAM-associated and Toll-like receptors. Nat. Immunol. 8, 619-629 (2007).
59. Hara, H. et al. Cell type-specific regulation of ITAM-mediated NF-κB activation by, the adaptors, CARMA1 and CARD9. J. Immunol. 181, 918-930 (2008).
60. Hsu, Y.M. et al. The adaptor protein-CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8 198-205 (2007).
61. Gringhuis, S.I. et al. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-κB activation through Raf-1 and Syk. Nat. Immunol. 10, 203-213 (2009).
62. Nguyen, K., Sylvain, N.R. & Bunnell, S.C. T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76. Immunity 28, 810-821 (2008).
63. Chaturvedi, A., Dorward, D. & Pierce, S.K. The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity 28, 799-809 (2008).
64. Ng, G. et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity 29, 807-818 (2008).
65. Chu, C.L. et al. Increased TLR responses in dendritic cells lacking the ITAM-containing adapters DAP12 and FcRγ. Eur. J. Immunol. 38, 166-173 (2008).
66. Cao, W. et al. Plasmacytoid dendritic cell-specific receptor ILT7-FcεRI γ inhibits Toll-like receptor-induced interferon production. J. Exp. Med. 203, 1399-1405 (2006).
67. Liew, F.Y., Xu, D., Brint, E.K. & O'Neill, L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5, 446-458 (2005).
68. Hu, X., Chakravarty, S.D. & Ivashkiv, L.B. Regulation of IFN and TLR signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms. Immunol. Rev. 226, 41-56 (2008).
69. Ji, J.D. et al. Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis. J. Exp. Med. 197, 1573-1583 (2003).
70. Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454-465 (2007).
71. Bode, J.G. et al. The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits IL-6-induced transcription. Biol. Chem. 382, 1447-1453 (2001).
72. Gerber, J.S. & Mosser, D.M. Reversing lipopolysaccharide toxicity by ligating the macrophage Fcγ receptors. J. Immunol. 166, 6861-6868 (20bl).
73. Polumuri, S.K., Toshchakov, V.Y. & Vogel, S.N. Role of phosphatidylinositol-3 kinase in transcriptional regulation of TLR-induced IL-12 and IL-10 by Fcγ receptor ligation in murine macrophages. J. Immunol. 179, 236-246 (2007).
74. Lucas M., Zhang, X., Prasanna, V. & Mosser, D.M. ERK activation following macrophage FcγR ligation leads to chromatin modifications at the IL-10 locus. J. Immunol. 175, 469-477 (2005).
75. Zhang, X., Edwards, J.P. & Mosser, D.M. Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J. Immunol. 177, 1282-1288 (2006).
76. Dillon, S. et al. Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J. Clin. Invest. 116, 916-928 (2006).
77. Dhodapkar, K.M. et al. Selective blockade ofthe inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med. 204, 1359-1369 (2007).
78. Helming, L. et al. Essential role of DAP12 signaling in macrophage programming into a fusion-competent state. Sci. Signal. 1, ra11 (2008).
79. Hida, S. et al. Fc receptor γ-chain, a constitutive component of the IL-3 receptor, is requrred for IL-3-induced IL-4 production in basophils. Nat. Immunol. 10, 214-222 (2009).
80. Lee, I.H., Li, W.P., Hisert, K.B. & Ivashkiv, L.B. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor mediated feedback inhibition of T cell expansion. J. Exp. Med. 190, 1263-1274 (1999).
81. Zhu, J. et al. Transient inhibition of interleukin 4 signaling by T cell receptor ligation. J. Exp. Med. 192, 1125-1134 (2000).
82. Park, J.H. et al. 'Coreceptor tuning': Cytokine signals transcriptionally tailor CD8 coreceptor expression to the self-specificity of the TCR. Nat. Immunol. 8, 1049-1059 (2007).
83. Du, Z. et al. Selective regulation of IL-10 signalling and function by zymosan. J. Immunol. 176, 4785-4792 (2006).
84. Du, Z. et al. Inhibition of IFN-α signaling by a PKC- and protein tyrosine phosphatase SHP-2-cippenclent pathway. Proc. Natl. Acad. Sci. USA 102, 10267-10272 (2005).
85. Park-Min, K.H. et al. FcγRIII-dependent inhibition of interferon-γ responses mediates suppressive effects of intravenous immune globulin. Immunity 26, 67-78 (2007).
86. Ochi, S. et al. Pathological role of osteoclast costimulation in arthritis-induced bone loss. Proc. Natl. Acad Sci. USA 104, 11394-11399 (2007).
87. Pearse, R.N., Feinman, R. & Ravetch, J.V. Characterization of the promoter of the human gene encoding the high-affinity IgG receptor: transcriptional induction by γ-interferon is mediated through common DNA response elements. Proc. Natl. Acad. Sci. USA 88, 11305-11309 (1991).
88. Bekeredjian-Ding, I. et al. TLR9-activating DNA up-regulates ZAP70 via sustained PKB induction in IgM+ B cells. J. Immunol. 161 8267-8277 (2008).
89. Liu, Y. et al. Cytokine-mediated regulation of activating and inhibitory Fcγ receptors in human monocytes. J. Leukoc. Biol. 77, 767-776 (2005).
90. Belostocki, K. et al. Infliximab treatment shifts the balance between stimulatory and inhibitory Fcγ receptor type II isoforms on neutrophils in patients with rheumatoid arthritis. Arthritis Rheum. 58, 384-388 (2008).
91. Miyazaki, T. et al. Pyk is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. Genes Dev. 12, 770-775 (1998).
92. Takaoka, A. et al. Protein tyrosine kinase Pyk2 mediates the Jak-dependent activation of MAPKand Stat1 in IFN-γbut not IFN-α, signaling. EMBO J. 18, 2480-2488 (1999).
93. Horng, T., Bezbradica, J.S. & Medzhitov, R. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat Immunol. 8, 1345-1352 (2007).
94. Chen, C. et al. The integrin α9β1 contributes to granulopoiesis by enhancing granulocyte colony-stimulating factor receptor signaling. Immunity 25, 895-906 (2006).
95. Rathlin, C.V.; Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124-1136 (2007).
96. Luo, B.H., Carman, C.V. & Springer, JA. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25, 619-647 (2007).
97. Avdi, N.J. et al. Tumor necrosis factor-α activatlon of the c-Jun N-terminal kinase pathway in human neutrophils. Integrin involvement in a pathway leading from cytoplasmic tyrosine kinases apoptosis. J. Biol. Chem. 276, 2189-2199 (2001).